Arvelle Therapeutics

Switzerland
Breíl, Grisons, Switzerland

Company profile

Arvelle Therapeutics company profile

Arvelle Therapeutics is a biopharmaceutical company with the mission of bringing innovative solutions to patients suffering from CNS disorders.

Business identity

Contact email
[email protected]
Phone number
(888) 317-1041
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$1M-$10M
Founded
2019-01-01, Year

Headquarters

Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
2
Total equity funding
$221.8M
Last funding
Series A / $42.7M / 2020-05-27
Last equity funding
Series A / $42.7M
Investors
7
Lead investors
1
Founders
3
Articles
6
Exited on
2021-01-04

Founders and investors

Founders

Gregory WeinhoffIlise LombardoMark Altmeyer

Lead investors

EQT Life Sciences

Investors

Andera PartnersEQT Life SciencesF-PrimeKB InvestmentNovaquest Capital Management